How Much Do Knee Gel Injections Cost?

Published on August 30, 2025 | Prices Last Reviewed for Freshness: January 2026
Written by Alec Pow - Economic & Pricing Investigator | Medical Review by Sarah Nguyen, MD

Educational content; not medical advice. Prices are typical estimates and may exclude insurance benefits; confirm with a licensed clinician and your insurer.

Knee gel injections, also called hyaluronic acid viscosupplementation, deliver a thick, lubricating gel into the joint to supplement synovial fluid and ease osteoarthritis pain. Clinics quote this as a package that combines the drug vial, a procedure fee for the major joint injection, optional ultrasound guidance, and sometimes a facility charge, if done in a hospital outpatient department. “How Much Does Knee Gel Injections Cost?” appears simple, yet bills vary widely by brand, site of care, and insurance details.

Typical candidates are adults with knee osteoarthritis who did not get enough relief from oral or topical pain medicine, activity changes, or steroid injections. Some plans require documentation and prior authorization. Medicare coverage is tied to local coverage determinations and medical necessity rules, and offices bill a drug code plus a CPT code for the injection, with a separate line if ultrasound guidance is used.

Article Insights

• Office cash menus show Synvisc-One near $670–$756 and Euflexxa near $275–$331 per visit.
• Pharmacy cash for single-shot brands often lists $1,043–$1,443 per syringe as of August 2025.
• Hospital outpatient bundles range $441–$1,796 per visit for Synvisc injection.
• Medicare covers gel when criteria are met, with 20 percent coinsurance after the deductible and possible specialty pharmacy routing.
• Budget $800–$1,600 for a three-shot office series at cash rates, or $670–$800 for a single-shot office bundle.

How Much Do Knee Gel Injections Cost?

Across the United States, a single office visit for knee gel injections can cost from a low cash bundle under $350 to pharmacy cash prices above $1,400 for a branded single-injection product, before any imaging or facility fees. Cash menus at orthopedic groups show self-pay for Synvisc-One near $670–$756 per knee, and Euflexxa near $275–$331 per dose for multi-injection series. Pharmacy cash for vials skews higher, with recent GoodRx “as low as” prices often around $1,043–$1,443 for single-injection brands as of August 2025.

Hospital outpatient bundles listed through consumer marketplaces show broader all-in totals from $441 to $1,796 for a Synvisc injection, which reflects the higher facility environment. Costs vary by brand. Timing affects the bill.

Insured patients experience a different pattern. When a deductible is not met, the patient responsibility can approach the full allowed amount for the drug plus the injection code and ultrasound. When the deductible is met, coinsurance and copays shrink the out-of-pocket.

Medicare commonly covers the drug under Part B with 20 percent coinsurance after the deductible, and offices may obtain product through specialty pharmacy pathways that change what appears on the bill. Coverage depends on prior authorization and on the local Medicare policy.

Table to frame expectations

The rows below summarize common patterns you will see in quotes and bills. Use it to sanity-check line items.

Sources reflect posted self-pay menus, pharmacy price trackers, and bundled marketplace offers, current as of August 2025.

The cost of knee gel injections in the US in 2025 generally ranges from about $500 to $1,500 per injection for hyaluronic acid injections, which are the most common type. Prices vary depending on the brand of injection, the healthcare provider, and the geographic location.

More advanced treatments like platelet-rich plasma (PRP) injections are more expensive, typically costing between $1,000 and $3,000 per treatment. Usually, patients require a series of injections, often spaced weeks apart, with total treatment costs ranging from $1,200 to $3,000 or more.

Insurance coverage significantly affects out-of-pocket costs. Medicare Part B often covers 80% of the cost for hyaluronic acid injections if medically necessary, after the deductible is met, leaving patients responsible for about 20% plus deductibles. Coverage varies among private insurance plans, with some offering full or partial payment. Patients without insurance or limited coverage face higher direct costs but may find clinics offering payment plans or package deals to offset expenses.

The effects of knee gel injections typically last several months, with hyaluronic acid injections providing relief often up to six months. The frequency and number of injections depend on individual patient needs and severity of knee osteoarthritis. Clinics may offer discounted pricing for multiple injections purchased upfront. Comparatively, high-end procedures like PRP injections require more preparation and expertise, contributing to their greater expense.

Real-Life Cost Examples

Scenario A, cash pay in a private office. A patient chooses a single-injection product with ultrasound guidance at an orthopedic clinic in Washington. The self-pay bundle for Synvisc-One is $756 per knee, which typically includes drug and the procedure. If the office adds a small ultrasound line or bandaging supplies, the total lands near $800–$850. A comparable multi-dose path with Euflexxa would be $275–$331 each visit for three visits, or roughly $825–$993 all-in if packaged the same way.

You might also like our articles about the cost of an Olux ring, an ORIF on an ankle, or knee replacement surgery.

Scenario B, PPO early in the plan year at a hospital outpatient department. A three-shot series is scheduled in the hospital clinic. The deductible is not met, so the patient responsibility includes the allowed drug charge each visit, the major joint injection code, ultrasound guidance, and a facility fee.

Real world outpatient bundles listed on MDSave range $441–$1,796 per Synvisc injection across markets. Three visits can reach $1,500–$3,500 for the patient until the deductible and coinsurance thresholds are satisfied.

Scenario C, Medicare in-network office. The practice bills the drug under Part B and the injection under CPT 20610 or 20611. After the Part B deductible, the patient pays 20 percent coinsurance on the allowed amounts, and many beneficiaries have a secondary plan that covers that portion.

Offices sometimes source the product via specialty pharmacy so the drug is billed to the pharmacy benefit, which changes what appears on the claim. Expect a moderate out-of-pocket if the deductible is already met.

Cost Breakdown

Drug and handling. The invoice lists a brand-specific HCPCS code such as J7325 for Synvisc or J7323-J7324 for other sodium hyaluronate products, with offices either buying and billing the drug or using a specialty pharmacy shipment to the clinic. Pharmacy cash trackers show single-injection brands often above $1,000 per syringe, while clinic self-pay menus can be lower due to wholesale purchasing.

Procedure and imaging fees. The major joint injection is billed with CPT 20610 without ultrasound or CPT 20611 with ultrasound guidance. These professional fees are separate from the drug charge, and a hospital outpatient department adds a facility component. Medicare’s coding article confirms billing the injection code in addition to the drug and outlines rules for same-day aspiration.

Visit and ancillaries. New patient or established visit, small supply items, aspiration if a large effusion is present, and post-injection materials can appear as line items. Bundled cash quotes may fold these into one figure, while insurance claims tend to split them.

Factors Influencing the Cost

Brand and formulation. Single-injection options like Synvisc-One or Monovisc concentrate the spend into one visit. Multi-injection series like Euflexxa or Supartz spread smaller per-visit totals across three to five appointments. Plans may prefer specific brands that reduce your copay, which shifts the final price.

Site of care and ultrasound. Offices usually cost less than hospital outpatient departments. Ultrasound guidance adds a CPT line and can improve accuracy for difficult knees, yet it raises the bill. When a practice treats ultrasound as standard, you will see it on every injection visit.

Insurance variables. Remaining deductible, coinsurance percentage, prior authorization, and whether the drug runs under the medical or pharmacy benefit change your out-of-pocket. Medicare relies on local coverage determinations with medical necessity criteria and frequency limits, and commercial policies mirror that structure.

Regional pricing and preference. Clinics in high-cost metros and academic centers may post higher self-pay menus. Physician preference for a brand also plays a role when supply tightens.

Alternative Products or Services

Steroid injections have much lower upfront prices, often $100–$300 in an office cash bundle, but relief tends to be shorter. Pharmacy and clinic data show gel courses cost more per episode, which fits their role as a later option when NSAIDs, bracing, and physical therapy did not provide enough relief.

Market reporting has highlighted the ongoing debate about clinical impact for hyaluronic acid, and guidelines from the American Academy of Orthopedic Surgeons describe mixed evidence while recognizing that some subsets may benefit. Platelet-rich plasma is offered by many sports medicine clinics, usually self-pay, and quotes often exceed $500–$1,500 per knee. Arthroplasty lives in a very different price tier and timeline.

Ways to Spend Less

Verify in-network status for both the clinician and the facility. Ask whether an office-based injection avoids a hospital facility fee. If you do not plan to use insurance, request a global cash price that bundles drug, administration, and ultrasound. Clinic menus in multiple markets show that approach cutting the single-visit total far below retail pharmacy cash for the vial.

Use price transparency tools and manufacturer programs. Bioventus has public rebate offers of $150 for Durolane and $50 for Gelsyn-3 at times, which can trim self-pay or high-deductible spend when allowed. If you anticipate other care this year, schedule after the deductible is met.

Expert Insights & Tips

Clinicians triage whether a gel series makes sense for your goals or whether a steroid injection or a physical therapy block is a better first move. Billing teams can tell you which documentation helps authorization, such as conservative care notes and imaging.

They can also explain coding so you can spot double charges, because the CPT 20610 or 20611 injection is billed once per knee even if aspiration and anesthetic are included that day. Ask if aspiration is bundled in the quote. Offices follow the CMS guidance for coding the injection plus the drug and show when ultrasound is added.

Total Costs (12–18 Months)

An annualized budget depends on brand and protocol. A single-injection course in an office cash bundle can be $670–$800, repeated every 6 to 12 months if it helps. A three-injection series priced $275–$331 per visit totals $825–$993 per knee, plus travel time. Patients combine gel with OTC analgesics, a few supervised physical therapy sessions, and bracing, which adds modest amounts. Hospital outpatient paths push higher due to facility fees, and insured patients see spend concentrated early in the plan year.

A simple worked example helps. One Synvisc-One office bundle at $756, plus a follow-up check at $110 and two PT sessions at $160 each, yields $1,186 for the season. If relief lasts nine months, that is your 12-month horizon unless you repeat sooner.

Hidden & Unexpected Costs

Authorizations that lag can push a series into a new deductible year, which raises out-of-pocket totals. Biologic shipments routed to a specific clinic lot may trigger reschedule or no-show fees if you cannot attend. Separate charges can appear for aspiration when a large effusion is present or for ultrasound images beyond the guidance code. Pharmacy versus medical benefit routing can swing your copay on the same brand.

Insurance, Support & “Warranty” 

Coverage often hinges on documented failure of conservative measures and on the plan’s policy for brand and frequency. Medicare contractors publish local coverage decisions that define reasonable and necessary use, and CMS articles outline the coding of the drug plus the injection service and the rule for same-day aspiration. Manufacturer hubs sometimes assist with benefit checks and appeals. Patients on federal insurance do not qualify for manufacturer copay cards, but they can still benefit from correct coding and the right site of care.

Financing & Payment Options

If paying cash, ask about prompt-pay discounts or clinic payment plans with zero interest windows. HSA and FSA funds can cover gel injections and the related visit and imaging. Itemized invoices help you submit to an HRA or employer wellness program. Avoid high interest medical credit unless the office offers a true promotional plan that fits your budget.

Opportunity Cost & ROI

Value is personal. Compare expected months of relief to the cost per course and to the frequency of lower-cost steroid injections. Include productivity and mobility value such as work days, caregiving, and exercise. Some patients use gel to postpone surgery, which can be sensible when relief is meaningful, yet keep a ledger of cumulative injection costs and function scores so you have your own return on investment. One long season of better mobility can be worth the spend, yet only if the relief is clear.

Seasonal & Market-Timing Factors

Scheduling matters. Many patients time gel after they reach the deductible threshold or before year-end resets. Specialty pharmacy shipments can slow around holidays, and clinics have seasonal swings tied to school sports. If travel complicates multiple visits, a single-injection product reduces trips and related expenses. Ask about slower clinic days that offer easier appointment slots and better chance for same-day ultrasound.

Brand & Series Selection (Cost Implications)

Single-injection brands reduce visit count. They often carry higher per-visit drug prices that are visible on pharmacy cash trackers. Multi-injection brands shift the spend into three smaller visits, which can be easier to budget and to fit into a deductible plan. Formularies can prefer specific products with lower copays, and storage or shipping rules may limit what an office keeps on hand. Follow your clinician’s plan that aligns with access and your insurance.

Answers to Common Questions

What price range should I expect per injection and per full series in an office versus a hospital setting?

Office cash bundles often land between $275 and $800 per injection. Hospital outpatient bundles listed on consumer marketplaces range $441–$1,796 per visit. Multi-dose series at office cash rates total about $800–$1,600.

How do deductible, copay, and coinsurance change my estimate with commercial insurance or Medicare?

Early in the year you might pay most of the allowed amount until the deductible is met. Medicare Part B commonly covers the drug and pays 80 percent of the allowed amount after the deductible, leaving 20 percent coinsurance that many supplemental plans cover.

Are ultrasound guidance and aspiration included or billed separately, and when do they add value?

Ultrasound guidance is billed with CPT 20611 and the injection is billed once per knee, even if aspiration occurs the same day. Some clinics bundle these in cash quotes, while insurance claims list them separately.

Can I get a cash-pay bundle, and what should be included to compare offers fairly?

Yes. Ask for drug, administration, and ultrasound in one figure, then confirm whether a brief follow-up is included. Compare against any facility fee if the practice uses a hospital outpatient department. Clinic menus in multiple markets publish those bundles.

How soon can a series be repeated, and how does that change a 12-month budget?

Many policies allow repeat series every 6 to 12 months when medically necessary. That cadence is the key driver of your annual total, since visit count and drug choice control most of the spend.

Sources, checked August 2025
American Academy of Orthopedic Surgeons guideline, 2021. CMS LCD and coding article for hyaluronic acid injections, current public versions. GoodRx pharmacy cash trackers for viscosupplements, 2023–2025. MDSave outpatient bundle ranges for Synvisc injection, accessed 2025. Olympia Orthopedic Associates self-pay pricing, accessed 2025.